SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : La Jolla Diagnostics, Inc.(OTC BB: LAJD)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Due Diligence who wrote (2)5/13/1998 8:20:00 AM
From: jeffrey rainey  Read Replies (1) of 168
 
Jimbo, here's something I sent to big Dog re: LAJD
Keep me up to date on what you find.
Regards
Jeff

PREVIEW - PUBLIC
To: Big Dog
From: jeffrey rainey Wednesday, May 13 1998 8:13AM EST
-Preview-

Big Dog

That's ok with me, just makes me dig a little deeper!
This sleeper has been on the list for a while now, but with the new Patent coming through it is becoming more and more interesting.
As posted Dan Brucker CEO has developed his company around this process called cluster "water" (us patent 5711950)

Here is a listing of their MANAGEMENT and all related credentials:
Hey I may be missing something but where's the the company lacking top professional staff?

7777 Fay Ave., Suite 160 La Jolla, CA 92037
Phone (800) 454-6790 Fax (619) 454-7851
E-mail LAJD Inc.

LAJD Management

Don Brucker is the Company's C.E.O. and is also responsible for business development, marketing and FDA regulatory affairs. He has been the executive manager for several successful businesses, and is the founder of Continuous Curve Contact Lenses, Inc. which became the world's second largest manufacturer of contact lens products largely because of Brucker's success in introducing a series of FDA approved lenses more efficiently than competition, and his innovative concepts in marketing new products. For several years Brucker's Hydrocurve series of soft contact lenses and solutions had more FDA clearances than the rest of the industry combined. After administrating a public offering of Continuous Curve in 1977, Brucker arranged for its sale to Revlon in 1981 for a value in excess of $100 million. Brucker became president of Revlon Vision Care with responsibility for all ophthalmic pharmaceutical products. Brucker was CEO of Immunetech Pharmaceuticals (later Dura Pharmaceuticals) during the period when several new drug applications (NDAs) were successfully initiated, and then served as a consultant for health care and medical device companies, with projects including the successful FDA submission for a new immunofluorescent diagnostic test for the screening for HIV antibody.

Robert N. Hamburger, M.D. is responsible, as the Medical Laboratory Director, for all clinical assays which are reported. He will ensure the quality and accuracy of all clinical diagnostic laboratory results before they are reported to the clinicians. Dr. Hamburger is professor emeritus from the UCSD School of Medicine where he was chairman of the Pediatric Allergy and Immunology Division. He has published over 200 articles, is the holder of three patents, and has achieved national and international recognition for his research in immunology.

Richard D. O'Connor, M.D. is responsible for selecting all immunodiagnostic and molecular immunological assays to be developed for clinical use. He will also be responsible for all clinical trials of all diagnostic assays. Dr. O'Connor is Chief of the Department of Asthma, Allergy and Clinical Immunology for Sharp Rees-Stealy at San Diego, California, and as the Director of the Department of Clinical Research, he has supervised more than 150 pharmaceutical clinical trials. Dr. O'Connor is a Clinical Professor of Pediatrics at UCSD School of Medicine and has published nearly one hundred articles in the field of Immunology and Allergy. He is the former Laboratory Director of the Immunology and Allergy Laboratory for the Department of Pediatrics at UCSD.

Robert Ziccardi, Ph.D. a protein chemist frokm the Scripps Institute is responsible for antibody purification. Dr. Zicarrdi received his Ph.D. in biochemistry from UCLA and in addition tohis work at Scripps, is an Adjunct Professor of Chemistry at Palomar College.

More to come as I think this comopany is about to wake up and many new product are on the horizion in the area of migraines and allergy medication.

Mr Bruckner seem very excited about the area of allergy medication and is moving rapidly in that area of care products.

All products have been "FDA cleared.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext